8.49
Precedente Chiudi:
$8.38
Aprire:
$8.37
Volume 24 ore:
210.57K
Relative Volume:
0.78
Capitalizzazione di mercato:
$568.63M
Reddito:
$555.06M
Utile/perdita netta:
$-39.48M
Rapporto P/E:
-14.15
EPS:
-0.6
Flusso di cassa netto:
$29.05M
1 W Prestazione:
+5.07%
1M Prestazione:
+7.06%
6M Prestazione:
+18.25%
1 anno Prestazione:
-18.29%
Bioventus Inc Stock (BVS) Company Profile
Nome
Bioventus Inc
Settore
Industria
Telefono
(919) 474-6700
Indirizzo
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Compare BVS vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BVS
Bioventus Inc
|
8.49 | 561.26M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Iniziato | Barrington Research | Outperform |
| 2025-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2022-11-22 | Downgrade | Craig Hallum | Buy → Hold |
| 2022-11-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Iniziato | Craig Hallum | Buy |
| 2021-11-15 | Ripresa | Morgan Stanley | Overweight |
| 2021-11-10 | Ripresa | JP Morgan | Overweight |
| 2021-07-01 | Downgrade | Goldman | Buy → Neutral |
| 2021-03-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-03-08 | Iniziato | Goldman | Buy |
| 2021-03-08 | Iniziato | JP Morgan | Overweight |
| 2021-03-08 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Bioventus Inc Borsa (BVS) Ultime notizie
Bioventus (BVS) versus Its Rivals Head-To-Head Comparison - Defense World
Comparing Bioventus (BVS) & Its Peers - Defense World
Bioventus (BVS) vs. Its Rivals Head to Head Review - Defense World
Reviewing Bioventus (BVS) and The Competition - Defense World
Understanding Momentum Shifts in (BVS) - Stock Traders Daily
Bioventus (BVS) vs. Its Rivals Head to Head Survey - Defense World
Bioventus (BVS) & Its Peers Head-To-Head Survey - Defense World
Barrington Research Initiates Coverage of Bioventus (BVS) with Outperform Recommendation - Nasdaq
Bioventus (BVS) vs. Its Rivals Financial Analysis - Defense World
Risks Report: Is Bioventus Inc. a top pick in the sectorEntry Point & Daily Risk Controlled Trade Plans - mfd.ru
Will Bioventus Inc. stock outperform Nasdaq indexNew Guidance & Fast Exit Strategy with Risk Control - mfd.ru
Will Bioventus Inc. stock maintain growth storyJuly 2025 Volume & Long-Term Investment Growth Plans - mfd.ru
Volatility Watch: Is Bioventus Inc. a top pick in the sectorOptions Play & Weekly Setup with ROI Potential - mfd.ru
Bioventus Inc. (BVS): Investor Outlook on a Potential 79% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Head-To-Head Review: Bioventus (BVS) vs. Its Rivals - Defense World
Chipmakers Recap: Is Bioventus Inc attractive for institutional investors2025 Valuation Update & Weekly High Return Stock Forecasts - baoquankhu1.vn
Recap Report: Is Bioventus Inc currently under institutional pressure2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Bioventus (NASDAQ:BVS) Upgraded at Barrington Research - MarketBeat
Those who invested in Bioventus (NASDAQ:BVS) three years ago are up 413% - Yahoo Finance
Bioventus (NYSE:BVS) Shares Gap UpWhat's Next? - MarketBeat
Bioventus (NASDAQ:BVS) Shares Gap UpHere's What Happened - MarketBeat
Barrington Initiates Bioventus at Outperform With $13 Price Target - marketscreener.com
Bioventus (NYSE:BVS) Earns Outperform Rating from Analysts at Barrington Research - MarketBeat
This Nokia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Avoiding Lag: Real-Time Signals in (BVS) Movement - Stock Traders Daily
Is Bioventus Inc. attractive for institutional investorsJuly 2025 Snapshot & Technical Pattern Based Buy Signals - baoquankhu1.vn
Bioventus (NASDAQ:BVS) Trading Up 1.4%Here's What Happened - MarketBeat
Bioventus (NASDAQ:BVS) Trading 1.4% HigherWhat's Next? - MarketBeat
Anderson Financial Strategies LLC Invests $901,000 in Bioventus Inc. $BVS - MarketBeat
Aug Selloffs: Will Bioventus Inc benefit from rising consumer demand2025 Support & Resistance & Reliable Intraday Trade Plans - baoquankhu1.vn
Is Bioventus Inc currently under institutional pressureEarnings Performance Report & Weekly Top Gainers Trade List - baoquankhu1.vn
Discipline and Rules-Based Execution in BVS Response - Stock Traders Daily
US Market Recap: What is Bioventus Incs valuation compared to sectorFed Meeting & Weekly Setup with ROI Potential - baoquankhu1.vn
Entry Recap: Can CNVS maintain sales growthGap Down & Accurate Technical Buy Alerts - baoquankhu1.vn
Published on: 2026-01-23 16:18:52 - baoquankhu1.vn
Bioventus (NYSE:BVS) Trading Up 3.8%Still a Buy? - MarketBeat
Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference - Defense World
Bioness $110M Sale Suit Heads to $8.9M Deal - Law360
Investment Recap: Is Bioventus Inc in a bullish channel2025 Risk Factors & High Conviction Buy Zone Picks - baoquankhu1.vn
Institutional investors own a significant stake of 36% in Bioventus Inc. (NASDAQ:BVS) - Yahoo Finance
Bioventus (NASDAQ:BVS) Stock Price Down 0.6%Should You Sell? - MarketBeat
Market Catalysts: Is Bioventus Inc currently under institutional pressure2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Trade Recap: Is Bioventus Inc stock gaining market shareProduct Launch & Safe Capital Preservation Plans - Bộ Nội Vụ
Recent uptick might appease Bioventus Inc. (NASDAQ:BVS) institutional owners after losing 13% over the past year - simplywall.st
What Wall Street predicts for Bioventus Inc. stock priceShort Setup & Weekly Sector Rotation Insights - ulpravda.ru
Why Bioventus Inc. stock could rally in 20252025 Short Interest & Accurate Buy Signal Alerts - Улправда
Will Bioventus Inc. stock deliver consistent dividendsDay Trade & High Accuracy Trade Alerts - Улправда
Is Bioventus Inc. stock gaining market share2025 Earnings Impact & Breakout Confirmation Trade Signals - Улправда
Can Bioventus Inc. stock sustain revenue growthJuly 2025 Spike Watch & Community Consensus Stock Picks - Улправда
How risky is Bioventus Inc. stock nowJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Will Bioventus Inc. stock return to pre crisis levelsJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - Улправда
Bioventus Inc Azioni (BVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):